EIP
BMY icon

Ellis Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Ellis Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$284K Buy
4,683
+896
+24% +$52.2K 0.05% 218
2025
Q4 		$204K Buy
+3,787
New +$182K 0.04% 247
2025
Q3 		– Sell
-4,321
Closed -$200K – 238
2025
Q2 		$200K Sell
4,321
-919
-18% -$45.1K 0.04% 236
2025
Q1 		$320K Buy
5,240
+54
+1% +$3.15K 0.07% 176
2024
Q4 		$293K Buy
5,186
+848
+20% +$47.4K 0.06% 185
2024
Q3 		$224K Buy
+4,338
New +$203K 0.04% 217
2024
Q2 		– Sell
-6,973
Closed -$378K – 230
2024
Q1 		$378K Sell
6,973
-845
-11% -$43K 0.08% 161
2023
Q4 		$401K Buy
7,818
+144
+2% +$7.56K 0.09% 148
2023
Q3 		$445K Buy
7,674
+137
+2% +$8.39K 0.11% 139
2023
Q2 		$482K Buy
7,537
+548
+8% +$36.7K 0.12% 138
2023
Q1 		$484K Sell
6,989
-181
-3% -$12.8K 0.13% 139
2022
Q4 		$516K Buy
7,170
+26
+0.4% +$1.96K 0.14% 127
2022
Q3 		$507K Sell
7,144
-510
-7% -$37K 0.14% 124
2022
Q2 		$589K Sell
7,654
-253
-3% -$19.3K 0.16% 115
2022
Q1 		$577K Sell
7,907
-1,969
-20% -$132K 0.14% 127
2021
Q4 		$615K Buy
9,876
+246
+3% +$14.4K 0.14% 123
2021
Q3 		$569K Buy
9,630
+1
+0% +$66 0.14% 119
2021
Q2 		$643K Buy
9,629
+617
+7% +$40.2K 0.16% 103
2021
Q1 		$569K Buy
9,012
+41
+0.5% +$2.55K 0.16% 112
2020
Q4 		$556K Sell
8,971
-36
-0.4% -$2.21K 0.17% 104
2020
Q3 		$543K Sell
9,007
-10
-0.1% -$602 0.19% 91
2020
Q2 		$535K Buy
9,017
+38
+0.4% +$2.27K 0.2% 90
2020
Q1 		$492K Sell
8,979
-1,463
-14% -$89.4K 0.23% 74
2019
Q4 		$661K Buy
10,442
+605
+6% +$34.6K 0.22% 83
2019
Q3 		$498K Buy
9,837
+56
+0.6% +$2.63K 0.18% 96
2019
Q2 		$451K Buy
9,781
+1,612
+20% +$75.1K 0.17% 96
2019
Q1 		$384K Buy
8,169
+2,892
+55% +$144K 0.16% 107
2018
Q4 		$274K Buy
+5,277
New +$284K 0.13% 123

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ellis Investment Partners's BMY Position: Q1 2026 in Review

Ellis Investment Partners increased its Bristol-Myers Squibb (BMY) stake by 24% in Q1 2026, buying an estimated $52.2K and bringing the position to 4,683 shares worth $284K. The position accounts for 0.05% of the portfolio, ranked #218.

Ellis Investment Partners first reported a position in BMY in Q4 2018 and has held it in 28 quarters since. The position peaked at $661K in Q4 2019. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Ellis Investment Partners held 4,683 shares of Bristol-Myers Squibb worth $284K as of Q1 2026.
  • Ellis Investment Partners bought 896 Bristol-Myers Squibb shares in Q1 2026, an estimated $52.2K.
  • Bristol-Myers Squibb made up 0.05% of Ellis Investment Partners's portfolio in Q1 2026, its #218 holding.
  • Ellis Investment Partners first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 28 quarters since.
  • Ellis Investment Partners's Bristol-Myers Squibb position peaked at $661K in Q4 2019.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Ellis Investment Partners's 13F filing for Q1 2026, filed 12 May 2026.